Browsing by Author "Al-Ziftawi,Nour"
Now showing items 1-4 of 4
-
CLINICAL AND PHARMACOECONOMIC ANALYSES OF CDK4/6 INHIBITORS USE IN STAGE IV BREAST CANCER FEMALES IN THE STATE OF QATAR: A COMPARATIVE RETROSPECTIVE OBSERVATIONAL STUDY WITH COST-EFFECTIVENESS AND COST-UTILITY ANALYSES
Al-Ziftawi, Nour Hisham (2021 , Master Thesis)Introduction: Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are indicated in the first-line treatment of hormonal receptor positive and HER-2 negative (HR+/HER2- negative) advanced breast cancer. Although phase III ... -
Community pharmacists' participation in adult vaccination: A cross-sectional survey based on the theoretical domains framework
El Hajj, Maguy Saffouh; Al-Ziftawi, Nour; Stewart, Derek; Al-Khater, Dhabya Mohamed A.Y. ( Wiley-Blackwell , 2022 , Article)Objectives: This study aims to assess Qatar community pharmacists' practices in advocating and promoting adult vaccination and to characterize and quantify potential determinants of participation in adult vaccination as ... -
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
Al-Ziftawi, Nour Hisham; Alam, Mohammed Fasihul; Elazzazy, Shereen; Shafie, Asrul Akmal; Hamad, Anas; Mohamed Ibrahim, Mohamed Izham... more authors ... less authors ( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ... -
Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease
Asmaa, Al-mansouri; Hamad, Abdullah Ibrahim; Al-Ali, Fadwa Saqr; Ibrahim, Mohamed Izham Mohamed; Kheir, Nadir; Al-Ziftawi, Nour Hisham; Ibrahim, Rania Abdelaziz; AlBakri, Muna; Awaisu, Ahmed... more authors ... less authors ( Elsevier , 2023 , Article)IntroductionChronic kidney disease (CKD) is associated with multimorbidity and high treatment burden. Pill-burden is one component of the overall treatment burden. However, little is known about its magnitude and contribution ...